Presented at the IASCLC 2020 North America Conference on Lung Cancer, October 16 to October 17, 2020.
Ravi Salgia1; Leigh M. Boehmer2; Catherine Celestin3; Hong Yu3; David R. Spigel4
1Department of Medical Oncology and Therapeutics Research, City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA; 2Editorial Content & Strategy, Association of Community Cancer Centers, Rockville, MD, USA; 3Oncology Group, AstraZeneca, Gaithersburg, MD, USA; 4Lung Cancer Research Program, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA
The Association of Community Cancer Centers (ACCC) has designed a quality metric for ideal NSCLC care, which has guided the development of a national survey to improve understanding of diagnosis and management of patients with stage III/IV NSCLC across different U.S.-based practice settings and to design and execute process improvement plans to address the identified barriers.
ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020
This project is made possible by support from AstraZeneca.